Preclinical Study Published in Nature Medicine Shows Anti-LINGO-1 Antibody Promotes Remyelination (Finanzen.net)
Biogen Idec (NASDAQ: BIIB) announced today the publication of findings from a preclinical study reporting that the anti-LINGO-1 antibody can promote spinal cord remyelination and axonal integrity, suggesting a potential role as a ...
Health & Living -
September 30, 2007 10:21 AM
You must login to add a comment. If you don't have a login, register here.